GWAS |
- Alzheimer's disease or HDL levels (pleiotropy) ( 30805717)
- Coronary artery disease ( 29212778)
- Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) ( 28714975)
- HDL cholesterol ( 24097068 30275531 25961943 20686565)
- HDL cholesterol levels ( 28334899 30698716)
- HDL cholesterol levels in current drinkers ( 30698716)
- HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716)
- HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716)
- High density lipoprotein cholesterol levels ( 29403010 31217584)
- Lipoprotein phospholipase A2 activity in cardiovascular disease ( 28753643)
- Lipoprotein-associated phospholipase A2 activity and mass ( 23118302 20442857)
- Lung function (FEV1) ( 30061609)
- Medication use (HMG CoA reductase inhibitors) ( 31015401)
- Metabolite levels (lipoprotein measures) ( 27005778)
- Renal cell carcinoma ( 21131975)
- Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis ( 26980576)
- Total bilirubin levels ( 29403010)
- Total cholesterol levels ( 29403010)
- Triglycerides ( 30275531)
- Vitamin E levels ( 21729881)
|
- Late-onset Alzheimer's disease ( 27770636)
- Waist-to-hip ratio adjusted for BMI ( 26426971)
- Waist-to-hip ratio adjusted for BMI (age >50) ( 26426971)
- Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) ( 26426971)
|